Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-20 Sale |
2023-01-24 8:08 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
267,000 | $1.11 | $296,370 | 745,975 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 8:05 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
164,155 | $1.2411 | $203,726 | 1,012,975 (Direct) |
View |
| 2022-10-07 Purchase |
2022-10-11 5:09 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
30,000 | $1.29 | $38,700 | 68,000 (Direct) |
View |
| 2022-10-06 Purchase |
2022-10-11 5:05 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
33,343 | $1.2878 | $42,940 | 63,343 (Direct) |
View |
| 2022-10-04 Purchase |
2022-10-05 4:43 pm |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
111,203 | $1.2815 | $142,512 | 473,117 (Direct) |
View |
| 2022-09-29 Purchase |
2022-10-03 5:19 pm |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
88,797 | $1.2444 | $110,500 | 361,914 (Direct) |
View |
| 2022-06-21 Purchase |
2022-06-23 5:08 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
10,000 | $1.05 | $10,500 | 1,173,058 (Direct) |
View |
| 2022-06-21 Purchase |
2022-06-23 5:07 pm |
Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO and President |
19,925 | $1.06 | $21,121 | 54,925 (Direct) |
View |
| 2022-03-01 Purchase |
2022-03-03 5:30 pm |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
27,708 | $1.69 | $46,827 | 273,117 (Direct) |
View |
| 2022-02-24 Purchase |
2022-02-28 5:57 pm |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
47,160 | $1.4778 | $69,694 | 245,409 (Direct) |
View |
| 2022-02-22 Purchase |
2022-02-23 5:42 pm |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
175,132 | $1.4673 | $256,970 | 198,249 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-29 Option Award |
2023-03-31 5:48 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:47 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:46 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:45 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:44 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:43 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2022-12-28 Option Award |
2022-12-29 5:01 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
14,230,418 | $0.8784 | 70,047,204 (Indirect) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:39 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
71,998 | $0 | 71,998 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:38 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
57,598 | $0 | 57,598 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:36 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
74,398 | $0 | 74,398 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:35 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | Haller Julia A Director |
42,239 | $0 | 42,239 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:34 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
42,239 | $0 | 42,239 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:33 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
74,878 | $0 | 74,878 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:31 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
38,399 | $0 | 38,399 (Direct) |
View |
| 2022-08-11 Option Award |
2022-08-15 5:16 pm |
N/A 2032-08-11 |
Outlook Therapeutics Inc. | OTLK | Haller Julia A Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-04-21 Other(A) |
2022-07-07 5:27 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
27,982,529 | $0 | 83,799,315 (Indirect) |
View |
| 2022-04-21 Other |
2022-04-22 4:38 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath GMS Ventures & Investments Director 10% Owner |
27,982,529 | $0 | 83,799,315 (Indirect) |
View |
| 2022-04-21 Other |
2022-04-22 4:33 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. 10% Owner |
27,982,529 | $0 | 50,965,058 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:47 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:46 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:44 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO and President |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:42 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
21,878 | $0 | 21,878 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:41 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
21,878 | $0 | 21,878 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:40 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
21,878 | $0 | 21,878 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:39 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
21,878 | $0 | 21,878 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:38 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
21,878 | $0 | 21,878 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:37 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
21,878 | $0 | 21,878 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:36 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
81,878 | $0 | 81,878 (Direct) |
View |